SETD1A drives proliferation of hormone receptor-positive breast cancer cells independent of its enzymatic activity

被引：0
|
作者：
Hayashi, Kanako [1 ,2 ]
Hoshii, Takayuki [1 ]
Matsumoto, Makoto [1 ]
Bahityar, Rahmutulla [1 ]
Fukuyo, Masaki [1 ]
Tanabe, Masahiko [2 ]
Seto, Yasuyuki [2 ]
Kaneda, Atsushi [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3031
引用
收藏
页码：1600 / 1600
页数：1
相关论文
共 50 条
  • [31] Fulvestrant in management of hormone receptor-positive metastatic breast cancer
    Shafaee, Maryam Nemati
    Ellis, Matthew James
    FUTURE ONCOLOGY, 2018, 14 (18) : 1789 - 1800
  • [32] Influence of Cimicifuga Racemosa on the Proliferation of Estrogen Receptor-Positive Human Breast Cancer Cells
    Cornelia Bodinet
    Johannes Freudenstein
    Breast Cancer Research and Treatment, 2002, 76 : 1 - 10
  • [33] Proteomic prediction in hormone receptor-positive breast cancer.
    Hennessy, B. T.
    Gonzalez-Angulo, A. M.
    Lu, Y.
    Tibes, R.
    Siwak, D.
    Sahin, A.
    Kau, S.
    Hortobagyi, G. N.
    Valero, V.
    Mills, G. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 13S - 13S
  • [34] Overcoming endocrine resistance in hormone receptor-positive breast cancer
    AlFakeeh, A.
    Brezden-Masley, C.
    CURRENT ONCOLOGY, 2018, 25 : S18 - S27
  • [35] A Therapeutic Target for Hormone-independent Estrogen Receptor-positive Breast Cancers
    Debajit K. Biswas
    Antonio Cruz
    Nicole Pettit
    George L. Mutter
    Arthur B. Pardee
    Molecular Medicine, 2001, 7 : 59 - 67
  • [36] A therapeutic target for hormone-independent estrogen receptor-positive breast cancers
    Biswas, DK
    Cruz, A
    Pettit, N
    Mutter, GL
    Pardee, AB
    MOLECULAR MEDICINE, 2001, 7 (01) : 59 - 67
  • [37] Impact of cyclin D1/TbRII cells in the sensitivity to tamoxifen in hormone receptor-positive breast cancer
    Babyshkina, N.
    Dronova, T.
    Vtorushin, S.
    Cherdyntseva, N.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1398 - S1398
  • [38] Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival
    Taroeno-Hariadi, Kartika Widayati
    Putra, Yasjudan Rastrama
    Choridah, Lina
    Widodo, Irianiwati
    Hardianti, Mardiah Suci
    Aryandono, Teguh
    JOURNAL OF BREAST CANCER, 2021, 24 (05) : 417 - 427
  • [39] Ibandronate inhibits the proliferation of estrogen receptor-positive breast cancer cells: Evidence for additivity with antiestrogens
    Journe, F
    Chaboteaux, C
    Laurent, G
    Dumon, JC
    Body, JJ
    BONE, 2004, 34 : S59 - S59
  • [40] Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer
    Lippman, Marc
    LANCET ONCOLOGY, 2019, 20 (03): : 312 - 313
12345